1. Home
  2. CVKD vs WAFU Comparison

CVKD vs WAFU Comparison

Compare CVKD & WAFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • WAFU
  • Stock Information
  • Founded
  • CVKD 2022
  • WAFU 1999
  • Country
  • CVKD United States
  • WAFU China
  • Employees
  • CVKD N/A
  • WAFU N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • WAFU Other Consumer Services
  • Sector
  • CVKD Health Care
  • WAFU Real Estate
  • Exchange
  • CVKD Nasdaq
  • WAFU Nasdaq
  • Market Cap
  • CVKD 8.2M
  • WAFU 8.3M
  • IPO Year
  • CVKD 2023
  • WAFU 2019
  • Fundamental
  • Price
  • CVKD $0.46
  • WAFU $1.99
  • Analyst Decision
  • CVKD Strong Buy
  • WAFU
  • Analyst Count
  • CVKD 2
  • WAFU 0
  • Target Price
  • CVKD $3.50
  • WAFU N/A
  • AVG Volume (30 Days)
  • CVKD 85.2K
  • WAFU 10.5K
  • Earning Date
  • CVKD 08-12-2024
  • WAFU 01-01-0001
  • Dividend Yield
  • CVKD N/A
  • WAFU N/A
  • EPS Growth
  • CVKD N/A
  • WAFU N/A
  • EPS
  • CVKD N/A
  • WAFU 0.06
  • Revenue
  • CVKD N/A
  • WAFU $8,887,515.00
  • Revenue This Year
  • CVKD N/A
  • WAFU N/A
  • Revenue Next Year
  • CVKD N/A
  • WAFU N/A
  • P/E Ratio
  • CVKD N/A
  • WAFU $33.18
  • Revenue Growth
  • CVKD N/A
  • WAFU N/A
  • 52 Week Low
  • CVKD $0.36
  • WAFU $1.58
  • 52 Week High
  • CVKD $2.17
  • WAFU $2.85
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 48.29
  • WAFU 56.09
  • Support Level
  • CVKD $0.43
  • WAFU $1.96
  • Resistance Level
  • CVKD $0.48
  • WAFU $2.06
  • Average True Range (ATR)
  • CVKD 0.03
  • WAFU 0.06
  • MACD
  • CVKD -0.00
  • WAFU 0.00
  • Stochastic Oscillator
  • CVKD 21.91
  • WAFU 63.68

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

About WAFU Wah Fu Education Group Limited

Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services, and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.

Share on Social Networks: